ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
BNP Paribas Issuance

BNP Paribas Issuance (P16JY0)

0.00
0.00
( 0.00% )
업데이트: -

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
-
매수가
-
매도가
-
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
-
개장가
-
최근 거래 시간
마지막 거래 시간
-
평균 볼륨(3m)
0.00
재정 규모
-
VWAP
-

P16JY0 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
15600102.45112.8587.500DE
2600099.35112.8587.50105.5DE

P16JY0 - Frequently Asked Questions (FAQ)

What is the current BNP Paribas Issuance share price?
The current share price of BNP Paribas Issuance is 0.00 €
What is the 1 year trading range for BNP Paribas Issuance share price?
BNP Paribas Issuance has traded in the range of 0.00 € to 0.00 € during the past year

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
WS3D25Solid World Group spa
0.1279 €
(27.90%)
152
PRTEsprinet
5.09 €
(11.62%)
636.73k
WART28DeodatoGallery SpA
0.0434 €
(10.71%)
18.55k
TDTrenDevice Spa
0.08 €
(9.89%)
211.5k
FIREBifire spa
2.52 €
(9.57%)
12k
1PUMPuma SE
22.03 €
(-22.46%)
31.91k
MPTImpianti SpA
0.74 €
(-12.43%)
463.5k
WHIK26Haiki Spa
0.09 €
(-8.63%)
203
CFMCrowdFundMe SpA
1.31 €
(-7.75%)
2.85k
1ITXIndustria De Diseno Textil SA
44.80 €
(-7.70%)
1.65k
TITTelecom Italia SpA
0.2737 €
(2.01%)
60.95M
ISPIntesa Sanpaolo Spa
4.793 €
(2.22%)
23.77M
SPMSaipem Spa
2.018 €
(2.59%)
20.89M
ENELEnel Spa
6.974 €
(0.16%)
7.62M
TITRTelecom Italia
0.3112 €
(1.87%)
6.74M
peafunke peafunke 4 분 전
Nice!
TPTW
navycmdr navycmdr 4 분 전
Steve Mnuchin on CNBC TV coming up next ...

CPI lower than expected Dow futures respond positively +246

will there be any Fannie/Freddie Housing comments ? ...

prob more comments/focus on Tariffs and recession fears
FNMA
GreenBackClub GreenBackClub 4 분 전
VOIP-PAL.COM, INC. v. Verizon Communications, Inc. et al
Texas Western District Court
Judge: Alan D Albright
Case #: 6:21-cv-00672
Nature of Suit 830 Property Rights - Patent
Cause 35:271 Patent Infringement
Case Filed: Jun 25, 2021
Terminated: Aug 15
VPLM
TechandBio TechandBio 5 분 전
https://fintel.io/i/m28-capital-management-lp

almost 70% of M28 Capital is in WVE that is lead and advised John Maraganore, PhD. Alnylam Pharmaceuticals. Cambridge, MA. Brook ... M28 Capital Management.

$WVE
WVE
Mk1969 Mk1969 5 분 전
He is right!
Craig305 Craig305 5 분 전
Que?
DesktopDR DesktopDR 5 분 전
Be careful with this one, they are about to be hit with a 268 bil anti-trust RICO lawsuit sometime this month.
TMUS
Ask$lapper Ask$lapper 5 분 전
GM LD!!
Imindog Imindog 5 분 전
Just do some basic math boys at .00030 x 1,000000 shares equals a grand total of $300 for the subsidary!! Lmao 🤣 you can’t make this trash up it’s straight garbage just like the ceo and company!! Hell it’s going to costs more to make the sale in closing and attorneys lmao 🤣
IQST
Gmenfan Gmenfan 5 분 전
Still sometimes getting the OPPS when going to my boards. Hit reload about 3 times and it appears even after I cleared the cookies and cache for this site. Moving between post once on the board seems to work fine, it's getting to the board(s) themselves that's the issue.
ProLiberty ProLiberty 6 분 전
Complete BS that they entertain a question about potentially acquiring another product and don't say a word about the requested and shareholder approved buyback that could instantly enhance shareholder value and leverage upside to growth the company anticipates.
AMRN
dinogreeves dinogreeves 6 분 전
Up 7% premarket, inflation report came out and it looked like it cooled off in February. Investors like it, momentum is there for sure.
SMCI
Debunkinator Debunkinator 6 분 전
The definitive Purchase Agreement is expected to be executed no later than July 1, 2025. The agreement includes a $250,000 penalty clause, ensuring ASII's commitment to completing the transaction.
ASII
lazarogusibahastockmarket lazarogusibahastockmarket 6 분 전
Grupo aval
MartinLutherKing MartinLutherKing 6 분 전
Bots get the party started brother, cancer cure moment up ahead🚀🚀
RNAZ
Retired2019 Retired2019 6 분 전
Don't they have to get Shareholder approval to execute a reverse stock split?
AMRN
BlazingStocks BlazingStocks 7 분 전
$BURU News March 12, 2025
NUBURU Takes Strategic Leap Forward: First Acquisition Step in Defense and Security Sector Completed
https://finance.yahoo.com/news/nuburu-takes-strategic-leap-forward-123000363.html
BURU
HenryB3 HenryB3 7 분 전
Kool aide talk going great. Mounting legal bills against a real big pharmaceutical company, just looks appealing for a buyout. Lol. Get real. Now let's compare to other deals. Sub 12 cents is around the corner. Bridges are being built, who wants one?
ELTP
rosemountbomber rosemountbomber 7 분 전
By the looks of premarket there is the answer to your question as to why 1 for 20 rather than 1 for something lower.  As long as it doesn't drop below 5 cents before April 11 the new stock price will still be above a buck
AMRN
JRoon71 JRoon71 7 분 전
Why would mgt. be doubling it’s efforts in a line item project srudying IPE?……..this is why the stock is undervalued, imo……

Have you been paying attention?

New formulation work, plus they specifically highlighted the potential of a synergy with GLP-1 receptors. That's h
GLP
georgie18 georgie18 7 분 전
HMTXF...089...🥳...OTC partnering with a NAZ company sounds proising to me...Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for
AIFF HMTXF
Trooperstocks Trooperstocks 7 분 전
NEWS: $ASII Accredited Solutions, Inc. (OTC: ASII) Engages Partner Capital Group, LLC (PartnerCap) to Explore Strategic Alternatives to Maximize Shareholder Value

Mar. 12, 2025 8:00 AM ET Source: Diamond Creek Water LLC.

NEW YORK, NY - March 12, 2025 (NEWMEDIAWIRE) - Ac
ASII IQST
chereb19 chereb19 7 분 전
No shares, your own cry.

https://investorshub.advfn.com/uimage/uploads/2025/3/3/qzphsisopet.JPG
RDGL
georgie18 georgie18 7 분 전
HMTXF...089...🥳...OTC partnering with a NAZ company sounds proising to me...Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for
AIFF HMTXF

최근 히스토리

Delayed Upgrade Clock